FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

419839008: Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3502075017 Acetaminophen 325 mg and propoxyphene napsylate 100 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681582012 Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681583019 Dextropropoxyphene napsylate 100 mg and paracetamol 325 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing paracetamol and propoxyphene napsylate false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient Dextropropoxyphene napsylate false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient Paracetamol false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Tablet false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient Dextropropoxyphene (substance) false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient Paracetamol false Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Paracetamol true Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 325 false Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value 1 false Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient Dextropropoxyphene napsylate false Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Dextropropoxyphene napsylate true Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 100 false Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value 1 false Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Dextropropoxyphene napsylate true Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Paracetamol true Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing dextropropoxyphene and paracetamol (medicinal product) false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient 2 false Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start